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Introduction
Insoluble deposits of β-amyloid (Aβ), in the form of senile 
plaques, and of tau, as neurofi  brillary tangles, have long been 
accepted as the primary histopathological markers of Alzheimer’s 
disease (AD). Although initial research focused on the role 
of Aβ and tau individually, recent evidence, including data 
demonstrating that amyloid pathology can up-regulate tau pa-
thology (Gotz et al., 2001; Lewis et al., 2001), defi  nes a signal-
ing pathway that leads from Aβ through tau (Lee et al., 2001; 
Selkoe, 2001; Hardy and Selkoe, 2002). Regrettably, the key 
steps within this pathway remain poorly understood.
A promising new focus of investigation has been the role 
that nonfi  brillar forms of Aβ, and to a lesser extent tau, play 
in AD. Soluble forms of Aβ are more potent than fi  brillar 
forms at eliciting cellular responses, such as increased apop-
tosis (Sponne et al., 2003) and decreased synaptic plasticity 
(Walsh et al., 2002). In fact, studies of transgenic animal 
  models and AD patients have shown that cognitive defi  cits 
and synaptic loss correlate with soluble Aβ, rather than senile 
plaques (Kayed et al., 2003; Oddo et al., 2006), suggesting 
that AD is initiated well before extracellular Aβ deposits 
are evident.
Neuronal microtubules serve as highways for axonal trans-
port  and, by extension, are critically involved in supporting 
  synaptic integrity and neuronal viability. The loss of axonal micro-
tubules is a hallmark of AD, and a longstanding question has 
been whether their loss or the accumulation of insoluble tau fi  l-
aments and Aβ plaques causes neurodegeneration. To shed light 
on this issue, we have used cultured neuronal and nonneuronal 
cells to model effects of various forms of Aβ on microtubules. 
Remarkably, we found that brief exposure of cells to submicro-
molar levels of prefi  brillar Aβ42 caused massive and rapid tau-
dependent disassembly of microtubules. Similar results were 
obtained for prefi  brillar Aβ40, albeit at much higher concentra-
tions, but microtubules in either tau-expressing or -defi  cient 
cells were relatively resistant to fi  brillar Aβ. Collectively, these 
results highlight the most dramatic, rapid, and sensitive link 
 between  Aβ and tau described to date, identify microtubules as 
primary, tau-dependent targets of Aβ, and suggest that non-
fi  brillar Aβ and tau underlie the detrimental neurodegenera-
tion observed in AD before the accumulation of fi  brillar forms 
in senile plaques and neurofi  brillary tangles.
Results and discussion
Coexpression of tau-CFP and YFP-tubulin in CV-1 African 
green monkey kidney cells, which do not express endogenous 
tau, allowed effects of various forms of Aβ on tau and tubulin 
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A
lzheimer’s Disease (AD) is deﬁ  ned histopatholog-
ically by extracellular β-amyloid (Aβ) ﬁ  brils plus 
intraneuronal tau ﬁ  laments. Studies of transgenic 
mice and cultured cells indicate that AD is caused by a 
pathological cascade in which Aβ lies upstream of tau, 
but the steps that connect Aβ to tau have remained 
  undeﬁ  ned. We demonstrate that tau confers acute hyper-
sensitivity of microtubules to preﬁ  brillar, extracellular Aβ 
in nonneuronal cells that express transfected tau and in 
cultured neurons that express endogenous tau. Preﬁ  brillar 
Aβ42 was active at submicromolar concentrations, several-
fold below those required for equivalent effects of preﬁ  -
brillar Aβ40, and microtubules were insensitive to ﬁ  brillar 
Aβ. The active region of tau was localized to an N-terminal 
domain that does not bind microtubules and is not part 
of the region of tau that assembles into ﬁ  laments. These 
results suggest that a seminal cell biological event in 
AD pathogenesis is acute, tau-dependent loss of micro-
tubule integrity caused by exposure of neurons to readily 
diffusible Aβ.
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distributions to be monitored in live cells by time-lapse fl  uores-
cence microscopy. Aβ is known to transition gradually from 
monomers to oligomers, protofi  brils, and fi  nally to highly stable 
fi  brils (Bitan et al., 2003). Because we did not observe any 
  consistent differences in behavior between freshly solubilized 
Aβ42, which is predominantly monomeric, versus Aβ42 en-
riched in octamers and larger oligomers that are recognized by 
a specifi  c antibody (Kayed et al., 2003), we refer to these forms 
of Aβ42 collectively as “prefi  brillar.” It must be noted, however, 
that oligomers were readily detectable in freshly solubilized 
Aβ42 (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200605187/DC1). Within 30 min to 3 h after adding 
0.1–3 μM prefi  brillar Aβ42 to culture media, tau dissociated 
from microtubules, which completely disassembled soon there-
after (Fig. 1 A and Video 1). Prefi  brillar Aβ40 was also capable 
of inducing tau-dependent microtubule disassembly in CV-1 cells, 
but at a minimum concentration of 3 μM (Video 2). In contrast, 
microtubules remained intact for >3 h when CV-1 cells ex-
pressing YFP-tubulin, but not tau-CFP, were exposed to as much 
as 3 μM prefi  brillar Aβ42 (Fig. 1 B and Video 3). Similarly, micro-
tubule integrity was unaffected in cells expressing tau-CFP 
after >2 h of exposure to as much as 3 μM fi  brillar Aβ42 (Fig. 
1 C and Video 4). Microtubule stability before and after expo-
sure of cells to prefi  brillar Aβ42 was also assessed using a bio-
chemical assay that partitions unassembled and polymerized 
tubulin into Triton X-100–soluble and –insoluble fractions, 
  respectively (Black et al., 1996). Prefi  brillar Aβ42 led to a 
  dramatic redistribution of tubulin into the unassembled fraction 
within 2 h of treatment (Fig. 1 D). This result was reinforced 
by quantitation of micrographs depicting Aβ42-induced micro-
tubule loss in cells that did or did not express tau-CFP (Fig. 1 E). 
We thus conclude that tau makes CV-1 cell microtubules hyper-
sensitive to prefi  brillar Aβ peptides, particularly Aβ42, but not 
to fi  brillar Aβ42.
Microtubule disassembly was also observed in primary rat 
cortical neurons after exposure to prefi  brillar Aβ42. Discrimina-
tion between polymerized and disassembled tubulin was not evi-
dent from immunostaining of the treated neurons. Nevertheless, 
the immunofl  uorescence images show that before prefi  brillar 
Aβ42 addition, the cells displayed numerous neuritic projections 
(Fig. 2 A). After only 30 min of cellular exposure to 1 μM prefi  -
brillar Aβ42, the neurites displayed swollen varicosities, and at 
later time points the cells appeared to lose the majority of their 
neuritic projections. Similar cultures were examined by electron 
microscopy (Fig. 2 B). Neurites in control cells typically con-
tained densely packed microtubules arranged in parallel. In con-
trast, neurites in cells treated with prefi  brillar Aβ42 contained 
fewer, less organized microtubules and conspicuous swellings 
that were fi  lled with membrane-bound organelles and were virtu-
ally devoid of microtubules. Similar fi  ndings have been reported 
for primary cortical neurons exposed to 5 μM oligomeric Aβ40 
for 3–6 h (Sponne et al., 2003; Fifre et al., 2006).
The biochemical assay for unassembled and polymerized 
tubulin (Black et al., 1996) was used to monitor the effects of 
Figure 1.  Tau-dependent hypersensitivity of 
CV-1 cell microtubules to preﬁ  brillar  A𝗃42. 
CV-1 cells transfected with tau-CFP and YFP-
  tubulin were treated with preﬁ  brillar Aβ42 as in-
dicated and imaged by time-lapse ﬂ  uorescence 
microscopy or analyzed by a biochemical as-
say for unassembled and polymerized tubulin 
(Black et al., 1996). (A) 1 μM preﬁ  brillar 
Aβ42 caused tau to dissociate from microtu-
bules and the microtubules to disassemble 
soon thereafter. (B) This effect required tau ex-
pression, because microtubules remained in-
tact in cells that expressed only YFP-tubulin 
and were treated with 3 μM preﬁ  brillar Aβ42. 
(C) Microtubules were unaffected in tau-
  expressing cells exposed to 3 μM ﬁ  brillar Aβ42. 
(D and E) Time-dependent microtubule loss in-
duced by preﬁ  brillar Aβ42 documented in D 
by fractionation of tubulin into soluble (S) and 
polymerized (P) pools (Black et al., 1996), 
and quantitation of ﬂ  uorescence micrographs 
of ﬁ  xed cells expressing Tau-CFP and counter-
stained with anti–α-tubulin (E). Error bars indi-
cate the SD, and transfected and nontransfected 
refer to cells that did and did not express Tau-
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prefi  brillar and fi  brillar Aβ42 on microtubule integrity in cul-
tured hippocampal neurons (Fig. 2 C). About 90% of the tubulin 
was polymerized in cells that were not exposed to Aβ42, but 
only 45% of the tubulin was polymerized after 2 h of exposure 
to 1 μM prefi  brillar Aβ42. Some microtubule loss (65% polym-
erized) was observed after a comparable exposure to fi  brillar 
Aβ42, but only at the much higher total peptide concentration 
of 3 μM.
Tau was found to be required for microtubule dis-
assembly in primary hippocampal neurons induced by prefi  -
brillar Aβ42. Neurons were treated with siRNA to reduce tau 
expression to trace levels (Fig. 2 D and Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200605187/DC1). 
After 2 h of  exposure to 2 μM prefi  brillar Aβ42, the level of po-
lymerized tubulin remained nearly unchanged in tau-defi  cient 
neurons ( 20% soluble tubulin), whereas the tau-expressing 
neurons again showed an increase in soluble tubulin ( 60% 
soluble tubulin). It was not possible to determine how much 
tau was microtubule bound or soluble in these experiments, 
because the tau was quantitatively solubilized by the Triton 
X-100 under conditions in which the polymerized tubulin was 
resistant to extraction (Black et al., 1996). Thus, the results for 
tubulin demonstrate that the endogenous tau in neurons, like 
transfected tau in CV-1 cells, makes microtubules acutely sen-
sitive to prefi  brillar Aβ42.
Treatment of tau-expressing neurons with prefi  brillar 
Aβ42 under conditions that induced microtubule disassembly 
did not cause increased AD-like tau phosphorylation at any 
of several sites (Fig. 3). This was found by immunoblotting us-
ing phosphorylation-sensitive monoclonal anti-tau antibodies: 
PHF-1, AT180, and tau-1. Although many additional AD-like 
Figure 2.  Tau-dependent hypersensitivity of neuronal microtu-
bules to preﬁ  brillar A𝗃42. Primary rat cortical neurons were cul-
tured for at least 8 d before treatment with preﬁ  brillar Aβ42. 
(A) Cells were stained by immunoﬂ  uorescence for tubulin (DM1A) 
and tau (R1tau) at the time points indicated after the addition of 
1 μM preﬁ  brillar Aβ42. Note the swollen varicosities induced by 
the Aβ42 (arrows). (B) Neurites in neurons treated for 2 h with 
1 μM preﬁ  brillar Aβ42 were found by electron microscopy to con-
tain numerous varicosities that were ﬁ  lled with membrane-bound 
organelles (asterisks) and lacked microtubules, and additional re-
gions with sparse, poorly organized microtubules (arrowheads). 
(C) Primary hippocampal neurons were extracted with Triton 
X-100 to separate the soluble (S) from polymerized (P) tubulin 
(Black et al., 1996). Note that  90% of the tubulin was polymer-
ized in control cultures, that only  45% was polymerized after 
2 h of cellular exposure to 1 μM preﬁ  brillar Aβ42, and that only a 
modest loss of polymerized tubulin (65% polymerized) was 
caused by a 2-h exposure to 3 μM ﬁ  brillar Aβ42. (D) Primary 
neurons were transfected with a tau-speciﬁ  c siRNA and treated 
with 2 μM preﬁ  brillar Aβ42 for 2 h before extraction. The siRNA-
treated cells expressed between 1/16 and 1/32 the normal 
level of tau (see Fig. S1, available at http://www.jcb.org/cgi/ 
content/full/jcb.200605187/DC1) and showed no change in 
tubulin levels in response to the Aβ42 treatment when compared 
with the tau-expressing cells.
Figure 3. Preﬁ  brillar A𝗃42 does not induce AD-like tau phosphorylation. 
Primary rat hippocampal neurons were treated with 1 μM Aβ42 for 2 h 
before Western blotting with the indicated anti-tau antibodies: PHF-1 (phos-
phoserine 396 and 404), AT180 (phosphoserine 231), and tau-1 (dephos-
phoserine 199 and 202). The phosphorylation of tau in treated neurons 
was compared with whole brain extract from an AD brain, as well as to 
paired helical ﬁ  laments puriﬁ  ed from an AD brain. Note that AD-like tau 
phosphorylation was not increased by preﬁ  brillar Aβ42.JCB • VOLUME 175 • NUMBER 4 • 2006  544
phosphorylation sites remain to be examined, these data suggest 
that conversion of tau to an AD-like phosphorylation state does 
not underlie the release of tau from microtubules and subse-
quent microtubule disassembly induced by prefi  brillar Aβ42.
The specifi  city of tau for microtubule loss in cells treated 
with prefi  brillar Aβ42 was shown by expressing GFP-tagged 
MAP2c in CV-1 cells. MAP2c is a neuron-specifi  c microtubule-
associated protein with a microtubule binding domain  70% 
identical to that of tau’s (Dehmelt and Halpain, 2005). 3 h of 
exposure to prefi  brillar Aβ42 did not cause any apparent loss of 
microtubule integrity in cells. A region of tau responsible for 
conferring sensitivity to Aβ42 was mapped using a combination 
of tau/MAP2c chimeric proteins and a CFP-tagged tau fragment. 
Only cells expressing “tau chimera,” a GFP-tagged protein 
comprising the microtubule binding domain of MAP2c fl  anked 
by the N-terminal arm and C-terminal tail of tau (Fig. 4 B 
and Videos 5–7, available at http://www.jcb.org/cgi/content/
full/jcb.200605187/DC1) responded to the addition of prefi  bril-
lar Aβ42. Similar activity was observed when the tau projection 
domain-CFP, which did not localize on microtubules, was ex-
pressed in cells that subsequently were treated with prefi  brillar 
Aβ42 (Fig. 4 B and Video 8). The qualitative results shown in 
Fig. 4 and Videos 1 and 4–8 were confi  rmed by quantitation of 
fl  uorescence micrographs for microtubule-containing cells be-
fore and after 3 h of exposure to prefi  brillar Aβ42 (Fig. 5). The 
N-terminal half of tau therefore responds to prefi  brillar Aβ42 
and does not have to target to microtubules to exert its effects. 
Furthermore, the closely related neuronal microtubule protein, 
MAP2c, cannot substitute for tau at promoting microtubule dis-
assembly in cells exposed to prefi  brillar Aβ42.
The nature of the functional connection between Aβ and 
tau has been one of the most enduring and intractable mysteries 
in AD research, and solving this mystery is bound to open po-
tential new avenues of early detection and therapeutic interven-
tion for AD. The results presented here represent the swiftest 
and most deleterious tau-dependent effects of Aβ that have yet 
been described. When considered together with recently pub-
lished studies demonstrating localization of oligomeric Aβ in 
AD brain at sites distinct from classic amyloid plaques (Kayed 
et al., 2003), a critical role for oligomeric Aβ in memory loss 
(Lesne et al., 2006), and colocalization of Aβ with tau in tangle-
bearing AD neurons in vivo (Guo et al., 2006), the present 
  results suggest a mechanism by which Aβ and tau conspire 
  coordinately to compromise neuronal function. Diminished 
Figure 4.  The active portion of tau resides within an N-terminal fragment that does not target to microtubules. CV-1 cells transfected with the indicated ﬂ  uo-
rescently tagged proteins were treated with 1 μM preﬁ  brillar Aβ42 and imaged by time-lapse ﬂ  uorescence microscopy. (A) Microtubules remained intact 
in cells expressing GFP-MAP2c or GFP-MAP2c chimera after >2 h of exposure to Aβ42. In contrast, microtubules depolymerized in cells expressing GFP-tau 
chimera after <1 h of exposure to Aβ42. (B) Microtubules also depolymerized in cells that were exposed to Aβ42 and expressed the N-terminal arm of 
tau coupled to CFP.TAU-DEPENDENT TOXICITY OF Aβ TO MICROTUBULES • KING ET AL. 545
  microtubule integrity could hinder essential microtubule func-
tions, such as axonal transport, which is required to maintain 
synapses, and delivery of exocytotic membranes to the cell sur-
face to repair plasma membrane holes (Shen et al., 2005) known 
to be induced by oligomeric Aβ (Kayed et al., 2003). The bio-
chemical steps that underlie tau-dependent microtubule poison-
ing by prefi  brillar Aβ remain unknown, but direct binding of tau 
to Aβ has been reported (Guo et al., 2006) and thus represents 
one possible step. Nevertheless, we have been unable to demon-
strate specifi  c coimmunoprecipitation of tau and Aβ out of tau-
expressing cells exposed to prefi  brillar Aβ42.
That the combination of prefi  brillar Aβ and nonfi  lamen-
tous tau were able to elicit such a dramatic disruption of micro-
tubules supports the hypothesis that fi  brillar forms of tau and Aβ 
are at least somewhat neuro-protective, because they sequester 
more dangerous, nonfi  brillar forms of Aβ and tau (Tanzi, 2005). 
The fact that tau is required for Aβ-induced microtubule loss 
could explain, at least in part, why neurons, the principal tau-
  expressing cell type, are the cellular targets for destruction in AD. 
Moreover, the model presented here does not preclude other 
toxic functions of prefi  brillar or fi  brillar Aβ or fi  lamentous tau, 
such as tau-dependent degeneration of cultured neurons induced 
by fi  brillar Aβ40 (Rapoport et al., 2002) or toxicity related to in-
tracellular tau fi  lament accumulation (Khlistunova et al., 2006). 
Nevertheless, the rapid, tau-dependent destruction of micro-
tubules that we observed to be induced by submicromolar con-
centrations of prefi  brillar Aβ42 suggests that this process is one 
of the seminal events in AD pathogenesis at the cellular level.
Materials and methods
Antibodies
Tau-5, Tau-1, and R1 anti-tau antibodies were gifts from L. Binder (North-
western University Medical School, Chicago, IL), and PHF-1 anti-tau was 
provided by P. Davies (Albert Einstein College of Medicine, New York, 
NY). AT180 anti-tau (Pierce Chemical Co.), DM1A anti-α-tubulin (Sigma-
Aldrich), C4 anti-actin (Chemicon), 6E10 anti-Aβ (Signet; recognizes all 
forms of Aβ40 and Aβ42), ﬂ  uorescently tagged goat anti–mouse IgG and 
goat anti–rabbit (Southern Biotechnology Associates, Inc.) and HRP-  labeled 
goat anti–mouse IgG (KPL) were acquired from the indicated commercial 
sources. I-11 is one of the Glabe laboratory’s rabbit polyclonal antibodies 
against oligomeric Aβ (Kayed et al., 2003).
Cell culture
CV-1 (African green monkey kidney) cells were cultured in DME (Invitro-
gen) supplemented with 10% Cosmic Calf Serum (Hyclone) and 50 μg/ml 
gentamycin. Cells were transiently transfected using Fugene (Roche) or a 
nucleofector (Amaxa) with cDNAs for the longest human isoform of tau or 
the projection domain (amino acids 1–248) of tau linked at their C termi-
nals to ECFP or EYFP (CLONTECH Laboratories, Inc.); with YFP–α-tubulin 
(CLONTECH Laboratories, Inc.); or with MAP2c or MAP2c/tau chimeras 
(Roger et al., 2004) tagged at their N termini with GFP, which were gifts 
from S. Halpain (The Scripps Research Institute, La Jolla, CA). For nucleo-
fection, program A-033 and solution V were used according to the manu-
facturer’s instructions. Primary cortical neurons were purchased from 
Genlantis and cultured according to their guidelines. Primary hippocampal 
neurons (Wisco et al., 2003) were grown for at least 8 d before Aβ treatment. 
The tau siRNA (SMARTpool; Dharmacon) and control scrambled siRNA 
(Nonspeciﬁ  c duplex II; Dharmacon) were transfected into primary hippo-
campal neurons by nucleofection using the rat neuron solution (Amaxa) 
and program G-13 (Qiang et al., 2006). Cells were cultured for 4 d after 
nucleofection and were then exposed to Aβ.
A𝗃 treatment
Previously described methods were used to synthesize (Burdick et al., 
1992) and resuspend (Kayed et al., 2003) Aβ42 and Aβ40. The Aβ was 
added to cells cultured in serum-free DME to ﬁ  nal concentrations from 0.1 
to 5 μM. Preﬁ  brillar Aβ was used in the ﬁ  rst and second days after resus-
pension, whereas ﬁ  brillar Aβ was used after at least 7 d of stirring.
Microscopy
Live cell imaging and immunoﬂ  uorescence microscopy were performed as 
previously described (Mateer et al., 2002) on an Axiovert 100 (Carl Zeiss 
MicroImaging, Inc.) equipped with 63× 1.4 NA planapo and 25× 0.8 
NA plan-neoﬂ   uar objectives (Carl Zeiss MicroImaging, Inc.), a CARV 
  spinning disk confocal head (BD Biosciences), an X-Cite 120 illuminator 
(EXFO Photonic Solutions), a cooled charge-coupled device (Orca ER; 
Hamamatsu), and OpenLab software (Improvision) for image acquisition 
and processing. For live cell time-lapse imaging, the cells were maintained 
on the microscope stage in DME at 37°C in an atmosphere of 95% air and 
5% CO2. The supplemental time-lapse videos were produced by ﬁ  rst using 
the public domain software, ImageJ to pseudocolor eight-bit grayscale 
  images stacks to eight-bit cyan, green, or yellow image stacks, and then 
  using QuickTime Pro 7 and Keynote 3 (Apple) to produce self-playing videos 
compressed with the H.264 codec. For electron microscopy, primary corti-
cal and hippocampal neurons were grown on glass coverslips, treated 
with Aβ42, and ﬁ  xed in 2.5% glutaraldehyde plus 0.5% tannic acid in 
0.1 M cacodylate buffer, pH 7.4. Cells on coverslips were dehydrated 
and capsule embedded in EPON, and the glass coverslip was removed 
from the EPON by alternating liquid nitrogen and warm water submersion 
of the capsule. Sectioned samples were viewed on an electron micro-
scope (JEM 1010; JEOL) at 80 kV, and images were captured using a 
16-megapixel cooled charge-coupled device (SAI-12c; Scientiﬁ  c  Instru-
ments and Applications, Inc).
Quantitation of ﬂ  uorescence micrographs
Nucleofection was used to express fusion proteins of CFP, GFP, or YFP cou-
pled to tau, the N-terminal tau arm, MAP2c, or MAP2c/tau chimeras in 
CV-1 cells growing on glass coverslips. Cultures that either were or were 
not exposed to preﬁ  brillar or ﬁ  brillar Aβ42 for 3 h were ﬁ  xed and permea-
bilized for 5 min in −20°C methanol and stained for immunoﬂ  uorescence 
with anti–α-tubulin followed by TRITC-labeled goat anti–mouse IgG. For 
each coverslip, six randomly chosen ﬁ   elds of view were photographed 
separately in both the TRITC channel and the CFP, GFP, or YFP channel us-
ing the 25× objective. Typically, 40–50% of the total cells expressed the 
transfected protein. Next, without knowing the identity of the sample, an 
observer counted the total cells and microtubule-containing cells in one 
anti-tubulin ﬁ  eld and then counted the total number of transfected cells and 
microtubule-containing transfected cells in the same ﬁ  eld. This process was 
Figure 5.  Quantitation of ﬂ   uorescence micrographs for A𝗃42-induced 
  microtubule loss. CV-1 cells expressing the indicated proteins with 40–50% 
transfection efﬁ  ciency were exposed to the form of Aβ42 speciﬁ  ed on the 
ﬁ  gure. The cells were then ﬁ  xed and stained with anti-tubulin and scored 
for microtubules as described in Materials and methods. Transfected and 
nontransfected refer to cells that did and did not express the indicated 
transgenes, respectively. Error bars indicate the SD, and asterisks mark sta-
tistically signiﬁ  cant differences at α = 0.02 between the indicated pairs of 
transfected and nontransfected cells after 3 h of Aβ exposure. Statistically 
signiﬁ  cant differences were not found for any pair of transfected versus 
nontransfected cells at 0 h, nor for any nontransfected pair at 0 versus 3 h. 
The collective results shown here conﬁ  rm the qualitative results shown in 
Figs. 1 and 4 and Videos 1 and 4–8 (available at http://www.jcb.org/cgi/
content/full/jcb.200605187/DC1).JCB • VOLUME 175 • NUMBER 4 • 2006  546
repeated for the remaining ﬁ  elds of the coverslip, and the results from all 
six ﬁ  elds, which comprised  500 total cells, were merged into a single 
dataset. Each such experiment was performed in triplicate, and the net re-
sults were graphed in Figs. 1 E and 5 as the mean ± SD of the percentage 
of microtubule-containing transfected and nontransfected cells for each 
  experimental condition. For Fig. 5, pairwise comparisons were made of 
transfected versus nontransfected cells at 0 and 3 h of Aβ exposure and of 
nontransfected cells at 0 versus 3 h of Aβ exposure.
Biochemical quantitation of unassembled and polymerized tubulin
CV-1 cells and primary hippocampal neurons were treated with 1–3 μM 
preﬁ  brillar or ﬁ  brillar Aβ42. Cells were washed brieﬂ  y with PBS and ex-
tracted with PHEM buffer (60 mM Pipes, pH 6.9, 25 mM Hepes, 10 mM 
EGTA, and 2 mM MgCl2) with 10 μM taxol and 0.2% Triton X-100 for 
5 min. The buffer was collected and centrifuged for 5 min at maximum 
speed in a table top centrifuge (model 5415; Eppendorf), and the superna-
tant was removed and mixed with 1/5 volume of 6× sample buffer for 
SDS-PAGE to generate a Triton-soluble fraction. An equivalent volume of 
PHEM buffer and 6× sample buffer was added to the dish, and this sample 
was added to the pellet from the spin to create a Triton-insoluble fraction. 
Equal volumes of Triton-soluble and -insoluble fractions, which contained 
soluble and polymerized tubulin, respectively (Black et al., 1996), were 
then analyzed by immunoblotting with anti–α-tubulin. Quantitation of 
scanned immunoreactive bands was performed using ImageJ.
Online supplemental material
Fig. S1 shows dot blots of preﬁ  brillar and ﬁ  brillar Aβ42 and control pro-
teins. Fig. S2 shows a Western blot of cell lysates from the scrambled 
siRNA- and tau siRNA–treated hippocampal neurons. Video 1 shows that 
microtubules disassemble in tau-expressing CV-1 cells exposed to preﬁ  bril-
lar Aβ42. Video 2 shows that microtubules disassemble in tau- expressing 
CV-1 cells exposed to preﬁ  brillar Aβ40. Video 3 shows that tau is required 
for preﬁ  brillar Aβ42 to induce microtubule disassembly. Video 4 demon-
strates that ﬁ  brillar Aβ42 does not induce microtubule disassembly in tau-
expressing cells. Video 5 shows that preﬁ  brillar Aβ42 does not induce 
microtubule disassembly in MAP2c-expressing cells. Video 6 demonstrates 
that preﬁ  brillar Aβ42 does not induce microtubule disassembly in cells ex-
pressing MAP2c chimera. Video 7 shows that preﬁ  brillar Aβ42 induces 
microtubule disassembly in cells expressing tau chimera. Video 8 demon-
strates that preﬁ  brillar Aβ42 induces microtubule disassembly in cells ex-
pressing the N-terminal tau arm. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200605187/DC1.
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